With the confirmation by our case of the possibility of myocardial metastasis from prostate cancer, with positive PSMA PET/CT results, the biopsy confirmation, and therefore the invasive investigation, to confirm the progression of disease at this unusual site becomes less necessary and allows for the avoidance of the adverse events associated with this procedure. This evidence concerns the gene FOLH1 and prostate carcinoma.